Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2003
06/14/2003CA2412464A1 Dextromethorphan tannate
06/14/2003CA2412463A1 Dextrochlorpheniramine tannate
06/12/2003WO2003048285A1 Organic compounds
06/12/2003WO2003048173A1 Chiral ligands for asymmetric catalysis
06/12/2003WO2003048158A1 Glycinamides as factor xa inhibitors
06/12/2003WO2003048155A1 Thrombin inhibitors
06/12/2003WO2003048128A1 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2003048115A1 Bacterial enzyme inhibitors
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003048108A2 Compounds for treatment of inflammation, diabetes and related disorders
06/12/2003WO2003048081A2 Glycinamides as factor xa inhibitors
06/12/2003WO2003047580A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
06/12/2003WO2003047579A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047564A1 Derivative having hiv integrase inhibitory activity
06/12/2003WO2002064094A3 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/12/2003WO2002050035A8 Insecticidal and fungicidal (2,6-dichloro-4-pyridyl) methylcarbamates used as plant protective agents
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
06/12/2003US20030109711 Process for the preparation of 4-haloalkylnicotinonitriles
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109703 Antiinflammatory agents; autoimmune disease
06/12/2003US20030109700 Antilipemic agents, anticholesterol agents, cardiovascular disorders, antiischemic agents
06/12/2003US20030109687 Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109555 Targeted drug delivery using sulfonamide derivatives
06/12/2003US20030109551 A therapeutic or preventive agent for pulmonary insufficiency, containing as an active ingredient a diaminotrifluoromethylpyridine derivative represented by the formula (I) or its salt: anti-inflammatory agent or an anti-
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109526 Azo amino acids derivatives
06/12/2003US20030109504 Inhibit metabotropic glutamate receptor activity, or activation, for use in the treatment of movement disorders associated with a poverty of movement (e.g. Parkinson's disease). The compounds are particularly useful when used in
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108970 Generating antibodies; quantitative analysis
06/12/2003US20030108771 Electroluminescent platinum compounds and devices made with such compounds
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468463A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
06/12/2003CA2468044A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
06/12/2003CA2467527A1 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318190A1 Organic compounds
06/11/2003EP1318147A1 Novel pyrimidine derivative and novel pyridine derivative
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317455A1 Process for preparing a substituted imidazopyridine compound
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317445A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317267A2 Compositions containing diacyltartaric salts of (e)-metanicotine
06/11/2003EP1317266A2 Neuroprotective 2-pyridinamine compositions and related methods
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423632A Aromatic diamide derivatives or salts thereof, agricultural/norticultural chemicals and method of using the same
06/11/2003CN1423631A Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423558A Novel processes for preparing torsemide intermediate
06/11/2003CN1422848A Pyridyl phenylurea preparation method
06/10/2003US6576783 Oligonucleotide protecting groups
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576747 Reacting alkylenediol and isatoic anhydride in presence of 1,4-diazabicyclo(2.2.2)octane and/or N,N,N*,N*-tetramethylenediamine; heating, decyclization, salt formation
06/10/2003US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives
06/10/2003US6576643 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation
06/10/2003US6576642 Inhibitors of the production of Ig E antibodies, antiallergens
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2303577C Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2133427C Enantiomeric 1-phenyl-2-(2-pyridinyl) ethylamine for the treatment of neurodegenerative disorders
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045903A1 Hydroxyethylene compounds with asp2 inhibitory activity
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003WO2003045367A1 Angiogenesis inhibitor
06/05/2003WO2003020241A9 Functional powders for oral delivery
06/05/2003WO2002048137A3 Substituted heterocyclic phthalic acid diamide arthropodicides
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105131 Aids therapy; antiinflamamtory agents; antiallergens; rheumatic diseases
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 633